Re-description of Parasphaerosyllis indica Monro, 1937 (Annelida, Syllidae), with the establishment of a new species from western Mexico

Parasphaerosyllis Monro, 1937 is a syllid genus, currently composed of four species: P. indica Monro, 1937 from the Arabian Sea, P. uschakovi (Chlebovitsch, 1959) from the Kurile Islands, P. ezoensis Imajima & Hartman, 1964 from Japan and P. malimalii Capa, San Martín & López, 2001 from the Pacific coast of Panama. The distribution of P. indica is circum-tropical to temperate waters, but the presence of species complexes has been suggested. In order to clarify the distribution of P. indica in many areas of the world, a re-description, based on examination of the type material, is required as a first step to a better understanding of its diagnostic features.Parasphaerosyllis indica is re-described, based on holotype examination, a new species is established from the Gulf of California and Parasphaerosyllis malimalii is reported for the first time since its description in 2001. Parasphaerosyllis irregulata sp. nov. is distinguished from its congeners by the following features: 1) Palps are free at their base; 2) Two types of dorsal cirri are present: spherical to bulbous and moniliform cirri; 3) Both types of cirri are distributed irregularly. A spherical/bulbous and moniliform cirrus may appear together within the same segment (asymmetrical segment) or only a spherical/bulbous cirrus may appear in several consecutive segments (not alternating as occurs in congeners); 4) The spherical/bulbous cirri may have distal knobs with 1–3 terminal articles; and 5) Bidentate falcigers with short, sub-triangular blades with a proximal tooth slightly larger that the distal one. A taxonomic key to species of Parasphaerosyllis species is included

Ethanolic Extract of Salvia hispanica L. Regulates Blood Pressure by Modulating the Expression of Genes Involved in BP-Regulatory Pathways

Hypertension (HT) is considered to be a potential risk factor for cardiovascular diseases and has been directly related to pathologies such as obesity and dyslipidemias. Angiotensin-converting enzyme inhibitors (ACEIs) blocked the renin-angiotensin-aldosterone cascade diminishing the production of angiotensin II and the level of bradykinin, produced by the kallikrein-kinin system. Although ACEIs are effective therapeutics in regulating HT, they present several side-effects that can be due to their mechanism of action (as hypotension, cough, dizziness, light-headedness or hyperkalemia) to specific drug molecular structure (skin rash, neutropenia and tasting disorders) or due to associated pathologies in the patients (it has been considered a possible nephrotoxic effect when ACEIs are administered in combination with angiotensin receptor blockers, in patients that present comorbidities as diabetes, acute kidney injury or chronic kidney disease). Therefore, it is necessary the searching for new products with ACEI activity that do not produce side effects. Interestingly, species of the plant genus Salvia have been found to possess hypotensive effects. In the present study, we analyzed the effects of the ethanolic extract of Salvia hispanica L. seeds (EESH) on the expression of genes involved in pathways regulating HT. Administration of EESH to hypertensive rats inhibited the angiotensin-converting enzyme (ACE) activity along with a decrease in Ace and elevation of Agtr1a and Nos3 gene expression, as compared to that in healthy rats. Moreover, these results were similar to those observed with captopril, an antihypertensive drug used as a control. No significant change in the expression of Bdkrb2 gene was observed in the different groups of rats. To conclude, our results demonstrate that EESH regulates blood pressure (BP) in hypertensive rats through transcriptionally regulating the expression of genes that participate in different pathways involving ACE